| 05/07/2026 10:29 AM | Adagene (1818838) Subject JANUS HENDERSON GROUP PLC (1274173) Filed by | Form SCHEDULE 13G | |
| 04/17/2026 3:00 PM | Adagene (1818838) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/02/2026 6:11 AM | Adagene (1818838) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/02/2026 5:59 AM | Adagene (1818838) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/02/2026 6:01 AM | Adagene (1818838) Filer | Form 424B5 | |
| 04/01/2026 4:15 PM | Adagene (1818838) Filer | Form 20-F Registration statement / Annual report / Transition report | |
| 04/01/2026 4:16 PM | Adagene (1818838) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/18/2026 8:22 AM | Adagene (1818838) Subject Chernett Jorey (2042077) Filed by | Form SCHEDULE 13G | |
| 03/18/2026 8:00 AM | Adagene (1818838) Issuer DO CUONG V (1477037) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 8:01 AM | Adagene (1818838) Issuer Zhao Qinghai (2115351) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 8:02 AM | Adagene (1818838) Issuer Cheung Andy Yiu Leung (2110863) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for ADAG and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Adagene and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/18/2026 8:02 AM | Adagene (1818838) Issuer GU CHUNFANG (2108105) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 8:03 AM | Adagene (1818838) Issuer Zhu Li (2104427) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 8:03 AM | Adagene (1818838) Issuer Zhou Ling (2112499) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 8:04 AM | Adagene (1818838) Issuer Luo Peter (1907614) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 8:04 AM | Adagene (1818838) Issuer Tam Man Kin (2106478) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 8:05 AM | Adagene (1818838) Issuer Chane-Du Mickael Yannick (2117912) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/17/2026 7:56 AM | Adagene (1818838) Issuer Grawunder Ulf (2120696) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 02/17/2026 3:30 PM | Adagene (1818838) Subject | Form SCHEDULE 13G/A | |
| 01/29/2026 3:16 PM | Adagene (1818838) Subject Smith Vincent C (1106662) Filed by | Form SCHEDULE 13G/A | |
| 01/23/2026 7:00 AM | Adagene (1818838) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/11/2026 11:15 PM | Adagene (1818838) Filer | Form EFFECT | |
| 01/09/2026 3:34 PM | Adagene (1818838) Filer | Form 424B3 | |
| 11/14/2025 4:42 PM | Adagene (1818838) Subject WuXi PharmaTech Healthcare Fund I L.P. (1678057) Filed by | Form SCHEDULE 13G/A | |
| 11/13/2025 6:00 AM | Adagene (1818838) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/31/2025 3:16 PM | Adagene (1818838) Filer | Form F-3 Registration statement for securities of certain foreign private issuers | |
| 07/15/2025 6:00 AM | Adagene (1818838) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/02/2025 12:53 PM | Adagene (1818838) Subject FMR LLC (315066) Filed by | Form SCHEDULE 13G/A | |
| 07/01/2025 7:30 AM | Adagene (1818838) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/01/2025 11:15 PM | Adagene (1818838) Filer | Form EFFECT | |
| 05/30/2025 4:05 PM | Adagene (1818838) Filer | Form 424B5 | |
| 05/23/2025 3:06 PM | Adagene (1818838) Filer | Form F-3/A | |
| 05/22/2025 4:05 PM | Adagene (1818838) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/15/2025 4:29 PM | Adagene (1818838) Subject WuXi PharmaTech Healthcare Fund I L.P. (1678057) Filed by | Form SCHEDULE 13G/A | |